Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences

ABSTRACT Recombination is a significant factor driving the evolution of RNA viruses. The prevalence and variation of porcine reproductive and respiratory syndrome virus (PRRSV) in China have been increasing in complexity due to extensive interlineage recombination. When this recombination phenomenon...

Full description

Saved in:
Bibliographic Details
Main Authors: Liwei Li, Jinxia Chen, Zhengda Cao, Ziqiang Guo, Jiachen Liu, Yanjun Zhou, Guangzhi Tong, Fei Gao
Format: Article
Language:English
Published: American Society for Microbiology 2025-02-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mbio.02350-24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832096539406761984
author Liwei Li
Jinxia Chen
Zhengda Cao
Ziqiang Guo
Jiachen Liu
Yanjun Zhou
Guangzhi Tong
Fei Gao
author_facet Liwei Li
Jinxia Chen
Zhengda Cao
Ziqiang Guo
Jiachen Liu
Yanjun Zhou
Guangzhi Tong
Fei Gao
author_sort Liwei Li
collection DOAJ
description ABSTRACT Recombination is a significant factor driving the evolution of RNA viruses. The prevalence and variation of porcine reproductive and respiratory syndrome virus (PRRSV) in China have been increasing in complexity due to extensive interlineage recombination. When this recombination phenomenon occurs in live vaccine strains, it becomes increasingly difficult to prevent and control PRRSV. Reverse genetic manipulation to engineer a different transcriptional regulatory sequence (TRS) circuit introduces genetic traps into the viral genome that are lethal to recombinant RNA progeny viruses. In this study, major interlineage recombination patterns were identified between lineage 1 (L1) PRRSVs and lineage 8 (L8) PRRSVs in China, from 2019 to 2023. The recombinant mutant virus, vA-TRSall, was constructed and successfully rescued by rewiring the entire TRS circuit without changing the amino acid-coding sequence in the genome of the PRRSV live vaccine strain vHuN4-F112. The vA-TRSall, with a brand new TRS circuit, provided effective immune protection against the highly pathogenic L8 PRRSV (vHuN4) and epidemic NADC30-like L1 PRRSV (vZJqz21). Recombination analysis in vitro and in vivo showed that, compared with the vHuN4-F112 and vZJqz21 co-infection groups, the incidence rates of mutation breakpoints and template-switching recombination in the vA-TRSall and vZJqz21 co-infected groups were effectively reduced. The results have enriched our understanding of the critical role of TRS circuits in PRRSV recombination mechanisms and indicate a successful redesign that can endow PRRSV live vaccines with recombination-resistant capabilities.IMPORTANCEPorcine reproductive and respiratory syndrome viruses (PRRSVs) are genetically diverse, and this is due in part to their extensive recombination. Live vaccines are widely used to prevent and control PRRS in China. However, owing to the wide variety of live vaccines, non-standard use, and the wild viruses prevalent on pig farms, new strains, generated via RNA recombination, are continuously emerging. Vaccine strains are also involved in PRRSV recombination, which leads to the emergence of new variants and alterations in virulence and pathogenesis. A recombination-resistant genome was engineered by rewiring the entire transcriptional regulatory sequence (TRS) circuit of the live PRRSV vaccine strain. Theoretically, after clinical application, once the virus recombines with the genome of the epidemic strain, the base pairing between the two sets of TRS circuits should be disrupted, resulting in a fatal genetic trap for the generation of an RNA recombinant progeny virus. Therefore, the remodeled PRRSV TRS mutant generated in this study can serve as a recombination-resistant platform for the rational design of safe PRRS vaccines in the future.
format Article
id doaj-art-c95057699c9f455fa4aeab9f31e9b7f6
institution Kabale University
issn 2150-7511
language English
publishDate 2025-02-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj-art-c95057699c9f455fa4aeab9f31e9b7f62025-02-05T14:00:48ZengAmerican Society for MicrobiologymBio2150-75112025-02-0116210.1128/mbio.02350-24Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequencesLiwei Li0Jinxia Chen1Zhengda Cao2Ziqiang Guo3Jiachen Liu4Yanjun Zhou5Guangzhi Tong6Fei Gao7Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaABSTRACT Recombination is a significant factor driving the evolution of RNA viruses. The prevalence and variation of porcine reproductive and respiratory syndrome virus (PRRSV) in China have been increasing in complexity due to extensive interlineage recombination. When this recombination phenomenon occurs in live vaccine strains, it becomes increasingly difficult to prevent and control PRRSV. Reverse genetic manipulation to engineer a different transcriptional regulatory sequence (TRS) circuit introduces genetic traps into the viral genome that are lethal to recombinant RNA progeny viruses. In this study, major interlineage recombination patterns were identified between lineage 1 (L1) PRRSVs and lineage 8 (L8) PRRSVs in China, from 2019 to 2023. The recombinant mutant virus, vA-TRSall, was constructed and successfully rescued by rewiring the entire TRS circuit without changing the amino acid-coding sequence in the genome of the PRRSV live vaccine strain vHuN4-F112. The vA-TRSall, with a brand new TRS circuit, provided effective immune protection against the highly pathogenic L8 PRRSV (vHuN4) and epidemic NADC30-like L1 PRRSV (vZJqz21). Recombination analysis in vitro and in vivo showed that, compared with the vHuN4-F112 and vZJqz21 co-infection groups, the incidence rates of mutation breakpoints and template-switching recombination in the vA-TRSall and vZJqz21 co-infected groups were effectively reduced. The results have enriched our understanding of the critical role of TRS circuits in PRRSV recombination mechanisms and indicate a successful redesign that can endow PRRSV live vaccines with recombination-resistant capabilities.IMPORTANCEPorcine reproductive and respiratory syndrome viruses (PRRSVs) are genetically diverse, and this is due in part to their extensive recombination. Live vaccines are widely used to prevent and control PRRS in China. However, owing to the wide variety of live vaccines, non-standard use, and the wild viruses prevalent on pig farms, new strains, generated via RNA recombination, are continuously emerging. Vaccine strains are also involved in PRRSV recombination, which leads to the emergence of new variants and alterations in virulence and pathogenesis. A recombination-resistant genome was engineered by rewiring the entire transcriptional regulatory sequence (TRS) circuit of the live PRRSV vaccine strain. Theoretically, after clinical application, once the virus recombines with the genome of the epidemic strain, the base pairing between the two sets of TRS circuits should be disrupted, resulting in a fatal genetic trap for the generation of an RNA recombinant progeny virus. Therefore, the remodeled PRRSV TRS mutant generated in this study can serve as a recombination-resistant platform for the rational design of safe PRRS vaccines in the future.https://journals.asm.org/doi/10.1128/mbio.02350-24RNA recombinationporcine reproductive and respiratory syndrome virus (PRRSV)transcriptional regulatory sequence (TRS)recombination-resistantvaccine redesign
spellingShingle Liwei Li
Jinxia Chen
Zhengda Cao
Ziqiang Guo
Jiachen Liu
Yanjun Zhou
Guangzhi Tong
Fei Gao
Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences
mBio
RNA recombination
porcine reproductive and respiratory syndrome virus (PRRSV)
transcriptional regulatory sequence (TRS)
recombination-resistant
vaccine redesign
title Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences
title_full Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences
title_fullStr Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences
title_full_unstemmed Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences
title_short Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences
title_sort engineering a live attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent rna recombination by rewiring transcriptional regulatory sequences
topic RNA recombination
porcine reproductive and respiratory syndrome virus (PRRSV)
transcriptional regulatory sequence (TRS)
recombination-resistant
vaccine redesign
url https://journals.asm.org/doi/10.1128/mbio.02350-24
work_keys_str_mv AT liweili engineeringaliveattenuatedporcinereproductiveandrespiratorysyndromevirusvaccinetopreventrnarecombinationbyrewiringtranscriptionalregulatorysequences
AT jinxiachen engineeringaliveattenuatedporcinereproductiveandrespiratorysyndromevirusvaccinetopreventrnarecombinationbyrewiringtranscriptionalregulatorysequences
AT zhengdacao engineeringaliveattenuatedporcinereproductiveandrespiratorysyndromevirusvaccinetopreventrnarecombinationbyrewiringtranscriptionalregulatorysequences
AT ziqiangguo engineeringaliveattenuatedporcinereproductiveandrespiratorysyndromevirusvaccinetopreventrnarecombinationbyrewiringtranscriptionalregulatorysequences
AT jiachenliu engineeringaliveattenuatedporcinereproductiveandrespiratorysyndromevirusvaccinetopreventrnarecombinationbyrewiringtranscriptionalregulatorysequences
AT yanjunzhou engineeringaliveattenuatedporcinereproductiveandrespiratorysyndromevirusvaccinetopreventrnarecombinationbyrewiringtranscriptionalregulatorysequences
AT guangzhitong engineeringaliveattenuatedporcinereproductiveandrespiratorysyndromevirusvaccinetopreventrnarecombinationbyrewiringtranscriptionalregulatorysequences
AT feigao engineeringaliveattenuatedporcinereproductiveandrespiratorysyndromevirusvaccinetopreventrnarecombinationbyrewiringtranscriptionalregulatorysequences